28400582|t|Detection of AMA-M2 in human saliva: Potentials in diagnosis and monitoring of primary biliary cholangitis
28400582|a|Serum anti-mitochondrial antibody type 2 (AMA-M2) is considered as a pivotal biomarker for the diagnosis of primary biliary cholangitis (PBC). However, serological tests have many limitations, including inconvenience, invasiveness, and infection risks. Thus, a less invasive approach to detect AMA-M2 titer is desirable. We examined salivary AMA-M2 of potential PBC patients and found that AMA-M2 could be detected only in saliva of serum AMA-M2-positive PBC patients, but not in saliva of serum AMA-M2-negative PBC patients, oral lichen planus patients (OLP) patients, or healthy controls. Furthermore, the concentration of salivary AMA-M2 was positively correlated with the amount of serum AMA-M2 in patients. The salivary inflammatory cytokines were increased in the PBC, consistent with the results of serum test. These findings indicated that saliva might be a less invasive and cost-effective medium to accurately test for AMA-M2 levels and this is a promising development for the diagnosis and monitoring of PBC.
28400582	0	9	Detection	T058	UMLS:C1511790
28400582	13	19	AMA-M2	T103	UMLS:C0312621
28400582	23	28	human	T204	UMLS:C0086418
28400582	29	35	saliva	T031	UMLS:C0036087
28400582	51	60	diagnosis	T033	UMLS:C0011900
28400582	65	75	monitoring	T058	UMLS:C1283169
28400582	79	106	primary biliary cholangitis	T038	UMLS:C0008312
28400582	107	112	Serum	T031	UMLS:C0229671
28400582	113	147	anti-mitochondrial antibody type 2	T103	UMLS:C0312621
28400582	149	155	AMA-M2	T103	UMLS:C0312621
28400582	184	193	biomarker	T201	UMLS:C0005516
28400582	202	211	diagnosis	T033	UMLS:C0011900
28400582	215	242	primary biliary cholangitis	T038	UMLS:C0008312
28400582	244	247	PBC	T038	UMLS:C0008312
28400582	259	276	serological tests	T058	UMLS:C0036743
28400582	343	358	infection risks	T033	UMLS:C0582147
28400582	382	390	approach	T082	UMLS:C0449445
28400582	394	400	detect	T033	UMLS:C0442726
28400582	401	413	AMA-M2 titer	T058	UMLS:C1446191
28400582	440	448	salivary	T031	UMLS:C0036087
28400582	449	455	AMA-M2	T103	UMLS:C0312621
28400582	469	472	PBC	T038	UMLS:C0008312
28400582	497	503	AMA-M2	T103	UMLS:C0312621
28400582	513	521	detected	T033	UMLS:C0442726
28400582	530	536	saliva	T031	UMLS:C0036087
28400582	540	545	serum	T031	UMLS:C0229671
28400582	546	561	AMA-M2-positive	T033	UMLS:C4021051
28400582	562	565	PBC	T038	UMLS:C0008312
28400582	587	593	saliva	T031	UMLS:C0036087
28400582	597	602	serum	T031	UMLS:C0229671
28400582	603	618	AMA-M2-negative	T033	UMLS:C0853205
28400582	619	622	PBC	T038	UMLS:C0008312
28400582	633	651	oral lichen planus	T038	UMLS:C0206139
28400582	662	665	OLP	T038	UMLS:C0206139
28400582	732	740	salivary	T031	UMLS:C0036087
28400582	741	747	AMA-M2	T103	UMLS:C0312621
28400582	793	798	serum	T031	UMLS:C0229671
28400582	799	805	AMA-M2	T103	UMLS:C0312621
28400582	823	831	salivary	T031	UMLS:C0036087
28400582	832	854	inflammatory cytokines	T103	UMLS:C0079189
28400582	877	880	PBC	T038	UMLS:C0008312
28400582	913	918	serum	T031	UMLS:C0229671
28400582	919	923	test	T058	UMLS:C0022885
28400582	955	961	saliva	T031	UMLS:C0036087
28400582	1036	1049	AMA-M2 levels	T058	UMLS:C2825862
28400582	1094	1103	diagnosis	T033	UMLS:C0011900
28400582	1108	1118	monitoring	T058	UMLS:C1283169
28400582	1122	1125	PBC	T038	UMLS:C0008312